Protocols›Cognitive & neuro›Calm & Sleep
← Protocols
Stress · anxiolyticResilience · daytimeRussia-registered

Stress & Resilience

Stack: Selank + Semax · the daytime, stress-facing side of the neuro category
"The daytime counterpart to Calm & Sleep. Selank takes the edge off anxiety without sedation or dependence; Semax is the stress-resilience and mental-clarity piece. Honest framing: both carry a real Russian clinical record but thin Western replication, and neither is a UK-licensed medicine."
GoalDaytime anxiety / stress resilience
Compounds2 · Selank + Semax
Human evidenceLimited–moderate — Russian clinical for both; limited Western RCTs
StatusUK: unlicensed research chemicals — not controlled, legal to possess, but not approved medicines. Russia: both registered (Selank for anxiety; Semax for cognition/stroke)
In this stack — snapshot; tap through for the full molecule file
Provenance & evidence layers — of the combination, not the parts
Registered use (Russia)
Selank
A registered anxiolytic medicine in Russia (Institute of Molecular Genetics), in clinical use for generalised anxiety since the 1990s.
Semax
Registered in Russia as a nootropic / neuroprotective medicine — used clinically for ischaemic stroke and cognitive indications.
Evidence it adds
Real-world Russian clinical exposure for both peptides.
Basis: Russian pharmacology registration (both)
Research / trial evidence
Selank
Russian RCTs describe anxiolytic and mild nootropic effects without the sedation or dependence of benzodiazepines — modest samples, limited Western replication.
Semax
Russian trials report neuroprotective and pro-cognitive effects, including in stroke recovery — again, little independent Western replication.
Evidence it adds
Moderate for both by Russian standards; thin outside Russia.
Basis: Russian clinical literature · limited Western RCTs
Grey-market / unsupervised use
Where / who
Both are sold as research peptides, usually intranasal, reconstituted from lyophilised powder.
What changes
Product identity, purity and dose are unverified; the Russian safety record belongs to the registered product, not a grey-market vial.
Evidence it adds
None — this layer is about how unsupervised use diverges from the studied product.
Basis: real-world sourcing — not a trial tier
Regulatory — read carefully
MHRA (UK)
Neither is a licensed medicine and neither is a controlled drug — unlicensed research chemicals. "Legal to possess" is not "approved or safe".
Elsewhere
Both are registered in Russia; not FDA- or EMA-approved.
What it means
Low apparent toxicity, but the strong evidence sits in Russian clinical practice, not Western trials.
Basis: MHRA: unlicensed, not scheduled
Why this pairing

Calm & Sleep covers the night — anxiety at bedtime and sleep onset. This pairing is the daytime counterpart, aimed at stress and anxiety while you’re awake and functioning. Selank is the anchor: a Russia-registered anxiolytic with a real, if modest, clinical record, used for anxiety without the sedation or dependence of benzodiazepines. Semax is its up-regulation sibling — a neuroprotective, pro-cognitive peptide studied for clarity and resilience under load. The honest framing: both carry genuine Russian clinical exposure but little Western replication, and neither is a UK-licensed medicine.

Members only · the actionable depth
See exactly how it's run
Doses, titration structure and what to monitor are part of membership. The provenance, evidence and status above are always free.
Get TiQ1 · Free →
Free · just create an account
Cycle shape — how it's typically structured, not a schedule to follow
Selank
intranasal, daily / as needed
Semax
intranasal, daytime
Review
cycle / reassess
Selank is typically used intranasally through the day or before stressful moments; Semax intranasally earlier in the day for clarity and stress resilience. These mirror community and Russian-clinical patterns, not a prescription to follow.
What's worth monitoring

Both peptides have a low reported toxicity profile, and Selank in particular is noted for the absence of sedation, tolerance or dependence seen with conventional anxiolytics. The real caveats are evidential and practical: the strong data lives in Russian clinical practice, Western replication is thin, and grey-market product identity and purity are unverified. Baseline sensibility and a clinician conversation are the floor. General information, not medical advice.

Evidence
Selank · anxiety Moderate

Russian clinical use for generalised anxiety — anxiolytic without sedation or dependence; limited Western replication.

Semax · stress / cognition Moderate

Russia-registered nootropic/neuroprotective; Russian trials in stroke and cognition, limited independent replication.

Unsupervised use Risk shifts

Grey-market identity and purity are unverified; the studied record belongs to the registered product.

The honest point

Both have a real Russian clinical record — but thin Western data. Evidenced in Russia, experimental here.

Fast facts
Compounds

Selank · Semax

Routes

Both intranasal

UK strip

GREEN — legal to possess (unlicensed)